EPHX2 and metabolic syndrome: One study demonstrates reduced soluble epoxide hydrolase (sEH) activity and implicates fatty acid diols in white adipose tissue (WAT) and liver during metabolic syndrome, suggesting novel mechanistic pathways (63).